Canada Pension Plan Investment Board’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.7M Buy
1,556,933
+129,257
+9% +$4.31M 0.03% 386
2026
Q1
$43M Buy
1,427,676
+80,891
+6% +$2.6M 0.03% 377
2025
Q4
$42M Buy
1,346,785
+755,571
+128% +$18.6M 0.03% 372
2025
Q3
$11.9M Buy
591,214
+201,654
+52% +$3.54M 0.01% 593
2025
Q2
$6.53M Buy
389,560
+238,922
+159% +$3.86M 0.01% 667
2025
Q1
$2.32M Buy
150,638
+78,638
+109% +$1.4M ﹤0.01% 790
2024
Q4
$1.59M Hold
72,000
– – ﹤0.01% 932
2024
Q3
$1.3M Hold
72,000
– – ﹤0.01% 948
2024
Q2
$1.17M Hold
72,000
– – ﹤0.01% 972
2024
Q1
$1.02M Hold
72,000
– – ﹤0.01% 1031
2023
Q4
$752K Hold
72,000
– – ﹤0.01% 986
2023
Q3
$734K Hold
72,000
– – ﹤0.01% 893
2023
Q2
$542K Sell
72,000
-26,200
-27% -$212K ﹤0.01% 900
2023
Q1
$869K Hold
98,200
– – ﹤0.01% 923
2022
Q4
$896K Hold
98,200
– – ﹤0.01% 876
2022
Q3
$792K Hold
98,200
– – ﹤0.01% 915
2022
Q2
$738K Buy
+98,200
New +$856K ﹤0.01% 880
2021
Q2
– Sell
-143,000
Closed -$1.65M – 1355
2021
Q1
$1.65M Sell
143,000
-35,586
-20% -$408K ﹤0.01% 905
2020
Q4
$1.72M Sell
178,586
-90,914
-34% -$871K ﹤0.01% 864
2020
Q3
$2.43M Buy
+269,500
New +$2.85M ﹤0.01% 604
2019
Q4
– Sell
-746,841
Closed -$5.14M – 1475
2019
Q3
$5.14M Hold
746,841
– – 0.01% 671
2019
Q2
$6.89M Buy
+746,841
New +$9.01M 0.01% 648
2019
Q1
– Sell
-78,000
Closed -$1.2M – 1625
2018
Q4
$1.2M Buy
+78,000
New +$1.6M ﹤0.01% 1056
2017
Q2
– Sell
-272,100
Closed -$8.73M – 1166
2017
Q1
$8.73M Sell
272,100
-136,610
-33% -$4.66M 0.02% 486
2016
Q4
$14.8M Sell
408,710
-603,100
-60% -$24.1M 0.05% 261
2016
Q3
$46.6M Buy
1,011,810
+998,000
+7,227% +$52.1M 0.17% 110
2016
Q2
$694K Sell
13,810
-1,061,600
-99% -$56.5M ﹤0.01% 829
2016
Q1
$57.5M Buy
1,075,410
+442,200
+70% +$25.9M 0.24% 78
2015
Q4
$41.6M Sell
633,210
-555,500
-47% -$34.3M 0.19% 85
2015
Q3
$67.1M Buy
1,188,710
+519,109
+78% +$33.7M 0.28% 62
2015
Q2
$39.6M Sell
669,601
-85,000
-11% -$5.24M 0.13% 137
2015
Q1
$47M Sell
754,601
-137,709
-15% -$8.01M 0.17% 118
2014
Q4
$51.3M Hold
892,310
– – 0.16% 113
2014
Q3
$48M Buy
892,310
+38,900
+5% +$2.06M 0.17% 109
2014
Q2
$44.7M Sell
853,410
-150,000
-15% -$7.67M 0.15% 126
2014
Q1
$53M Buy
1,003,410
+307,827
+44% +$14.2M 0.21% 102
2013
Q4
$27.9M Sell
695,583
-421,900
-38% -$16.6M 0.11% 185
2013
Q3
$42.2M Buy
1,117,483
+15,100
+1% +$589K 0.19% 127
2013
Q2
$43.2M Buy
+1,102,383
New +$42.9M 0.22% 119

Other funds holding TEVA

Canada Pension Plan Investment Board's TEVA Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 9.1% in Q2 2026, buying an estimated $4.31M and bringing the position to 1,556,933 shares worth $52.7M. The position accounts for 0.03% of the portfolio, ranked #386.

Canada Pension Plan Investment Board first reported a position in TEVA in Q2 2013 and has held it in 39 quarters since. The position peaked at $67.1M in Q3 2015. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Canada Pension Plan Investment Board held 1,556,933 shares of Teva Pharmaceutical Industries Limited worth $52.7M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 129,257 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $4.31M.
  • Teva Pharmaceutical Industries Limited made up 0.03% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #386 holding.
  • Canada Pension Plan Investment Board first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 39 quarters since.
  • Canada Pension Plan Investment Board's Teva Pharmaceutical Industries Limited position peaked at $67.1M in Q3 2015.
  • 677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.